Diazepam
Brand names: Valium, Diazemuls (IV emulsion), Stesolid (rectal)
Adult dose
Paediatric dose
Dose adjustments
No specific adjustment but caution.
Reduce dose 50% in moderate impairment; AVOID in severe — accumulation, risk of hepatic encephalopathy. Use lorazepam (no active metabolites) instead.
Status epilepticus: 0.3 mg/kg IV (max 10 mg) or 0.5 mg/kg PR (max 20 mg). Repeat after 10 min if seizure persists. Febrile convulsions: rectal Stesolid 5 mg <3 yrs, 10 mg ≥3 yrs. APLS Pathway.
Clinical pearls
- First-line for status epilepticus IV (10 mg) or rectal (10–20 mg PR) per APLS / NICE — buccal midazolam 10 mg is now often preferred in community for convulsive seizures.
- Alcohol withdrawal: equivalent to chlordiazepoxide; some centres prefer diazepam for smoother taper due to long active-metabolite half-life (less inter-dose anxiety).
- DO NOT use IM — absorption is erratic and slower than oral.
- Diazemuls IV (5 mg/ml lipid emulsion) reduces thrombophlebitis; aqueous Valium injection should be diluted and given slowly.
- Equivalent doses: diazepam 10 mg ≈ chlordiazepoxide 25 mg ≈ lorazepam 1 mg ≈ alprazolam 1 mg ≈ temazepam 20 mg.
- Falls risk in elderly is dose-related and significant — review need every 4 weeks; taper by 10% every 1–2 weeks if discontinuing chronic use.
- If chronic prescription, check for misuse/diversion risk and review necessity at every consultation.
Contraindications
- Severe respiratory disease, sleep apnoea
- Severe hepatic impairment
- Myasthenia gravis
- Acute narrow-angle glaucoma
- Phobic or obsessional states (relative — risk of dependence)
- Pregnancy and breastfeeding (relative — neonatal effects)
- Concurrent strong opioids (relative — major mortality risk)
Side effects
- Sedation, drowsiness, ataxia
- Anterograde amnesia
- Falls and hip fractures (especially elderly)
- Respiratory depression (esp. with opioids — black-box warning)
- Tolerance, dependence, withdrawal seizures
- Paradoxical reactions: agitation, aggression, disinhibition
- Hangover effect (long t½)
- Thrombophlebitis (IV — use Diazemuls emulsion)
- Apnoea after rapid IV push
Interactions
- Opioids: fatal respiratory depression — MHRA black-box warning
- Alcohol: additive CNS / respiratory depression
- CYP3A4 inhibitors (fluconazole, ritonavir, cimetidine): ↑ levels
- CYP3A4 inducers (rifampicin, phenytoin, carbamazepine): ↓ levels
- Other CNS depressants (gabapentinoids, antipsychotics): additive
- Levodopa: theoretical reduction in efficacy
Monitoring
- Sedation, respiratory rate (acute IV use)
- Falls risk (elderly)
- Review need every 2–4 weeks for chronic use
Reference: BNFc; BNF 90; BNF for Children 2024; NICE NG217 (Epilepsies in adults 2022); APLS Pathway; MHRA Drug Safety Update Apr 2020 (benzodiazepines + opioids); SmPC Diazemuls. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
- Corrected QT Interval (Bazett) · ECG
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- Benzodiazepine Conversion Calculator · Drug Conversion
- Oakland Score for Lower GI Bleeding · GI Bleeding
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care